ENRUHE
PF-Atlas › Clinical Trials › NCT02677701

Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With Cystic Fibrosis

azithromycin · Phase 4

Registry ID
NCT02677701
Phase
Phase 4
Status
Completed
Drug / intervention
azithromycin
Sponsor
Seattle Children's Hospital
Start
2016-10-21

About this trial

azithromycin is evaluated in NCT02677701, a Phase 4 idiopathic pulmonary fibrosis study sponsored by Seattle Children's Hospital. Current status: Completed.

View NCT02677701 on ClinicalTrials.gov →

Explore related

All azithromycin trialsAll IPF trials

Related trials

azithromycin — NCT02173145Azithromycin — NCT01270074Azithromycin — NCT05842681Azithromycin — NCT02960503Azithromycin — NCT02003911Azithromycin — NCT02803944
Medical disclaimer. This page summarizes public trial data for NCT02677701 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.